Passive Enhanced Safety Surveillance of Stamaril® Vaccine in Korea
NCT03541694 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 622
Last updated 2019-03-26
Summary
This is a passive enhance safety surveillance (ESS) of Stamaril® vaccine in Korea. The objective is to collect suspected related adverse events following vaccination with Stamaril® in routine practice.
Conditions
- Yellow Fever
Interventions
- BIOLOGICAL
-
Stamaril®
Routine vaccination with Stamaril yellow fever vaccine
Sponsors & Collaborators
-
Sanofi Pasteur, a Sanofi Company
lead INDUSTRY
Principal Investigators
-
Medical Director · Sanofi Pasteur, a Sanofi Company
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-04-11
- Primary Completion
- 2018-05-30
- Completion
- 2018-05-30
Countries
- South Korea
Study Locations
More Related Trials
-
Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers
NCT01436396 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)
NCT00982137 ·Status: COMPLETED ·Phase: PHASE2
-
ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)
NCT01556451 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults
NCT07002060 ·Status: COMPLETED ·Phase: PHASE3
-
Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines
NCT01765413 ·Status: COMPLETED ·Phase: NA
-
Yellow Fever Virus Vaccine and Immune Globulin Study
NCT00254826 ·Status: COMPLETED ·Phase: PHASE1
-
Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA
NCT04942210 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults
NCT05559983 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults
NCT04142086 ·Status: COMPLETED ·Phase: PHASE1
-
Human Immune Responses to Yellow Fever Vaccination
NCT00694655 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever Vaccine
NCT05374317 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 3 Lot-consistency Clinical Trial of Live Attenuated Varicella Vaccine
NCT03555071 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Evaluation of a Q-fever Vaccine, NDBR 105
NCT00584454 ·Status: COMPLETED ·Phase: PHASE2
-
Description of the Immune Response to Yellow Fever Vaccination
NCT06718127 ·Status: RECRUITING ·Phase: NA
-
Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE)
NCT02991495 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers
NCT02743455 ·Status: COMPLETED ·Phase: PHASE1
-
Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Anhui Province
NCT05470855 ·Status: UNKNOWN ·Phase: PHASE4
-
An Immunity Persistence Study of Live Attenuated Varicella Vaccine
NCT05095701 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine
NCT00584844 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Yellow Fever Inactivated Vaccine
NCT00995865 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 3 Single Arm, Open Study on vYF in Adults
NCT07222059 ·Status: COMPLETED ·Phase: PHASE3
-
Optimal Timing of Zoster Vaccine After Zoster Illness
NCT02704572 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females
NCT01101542 ·Status: COMPLETED
-
Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old
NCT05015686 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Non- Inferiority Fractional-doses Trial for Yellow Fever Vaccine
NCT04059471 ·Status: COMPLETED ·Phase: PHASE4